Copyright
©The Author(s) 2020.
World J Gastroenterol. Feb 14, 2020; 26(6): 670-685
Published online Feb 14, 2020. doi: 10.3748/wjg.v26.i6.670
Published online Feb 14, 2020. doi: 10.3748/wjg.v26.i6.670
Factors | 3-yr univariate Cox | 3-yr multivariate Cox | ||
P value | H (95%CI) | P value | HR (95%CI) | |
Gender (male vs female) | 0.803 | 1.075 (0.608-1.903) | ||
Age (≥ 60 yr vs < 65 yr) | 0.534 | 0.835 (0.473-1.474) | ||
Lesion location (upper vs middle vs lower) | 0.427 | 1.166 (0.798-1.705) | ||
Tumor size (≥ 3 cm vs < 3 cm) | 0.000 | 3.473 (1.827-6.601) | 0.010 | 2.402 (1.237-4.665) |
Differentiation (low differentiation vs moderate + high differentiation) | 0.000 | 3.09 (1.724-5.539) | 0.015 | 2.153 (1.159-4.002) |
TNM stage (stage I vs stage II + III) | 0.060 | 0.543 (0.287-1.027) | ||
Adjuvant therapy plan (chemotherapy vs radiotherapy) | 0.939 | 1.025 (0.549-1.911) | ||
Recurrence (recurrence vs non-recurrence) | 0.002 | 2.561 (1.408-4.657) | 0.034 | 1.949 (1.05-3.619) |
miR-1304 (high expression vs low expression) | 0.001 | 2.614 (1.448-4.717) | 0.036 | 1.93 (1.044-3.565) |
- Citation: Luo YG, Duan LW, Ji X, Jia WY, Liu Y, Sun ML, Liu GM. Expression of miR-1304 in patients with esophageal carcinoma and risk factors for recurrence. World J Gastroenterol 2020; 26(6): 670-685
- URL: https://www.wjgnet.com/1007-9327/full/v26/i6/670.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i6.670